Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Uniphos Enterprises
Join Channel
Consolidated Standalone

Uniphos Enterprises

₹151.6 2.8 | 1.8%

Market Cap ₹1054 Cr.

Stock P/E 26.5

P/B 0.4

Current Price ₹151.6

Book Value ₹ 358.4

Face Value 2

52W High ₹183.8

Dividend Yield 4.29%

52W Low ₹ 127

Edit Ratio

Uniphos Enterprises Research see more...

Overview Inc. Year: 1969Industry: Trading

Uniphos Enterprises Ltd is an India-based enterprise, that's engaged in trading activities. The Company is concerned inside the business of trading of chemical substances and other products. The Company is likewise keeping equity stocks of UPL Ltd. Nerka Chemicals Pvt Ltd is the holding organization of the Company. The Company's ultimate holding organisation is Demuric Holdings Pvt Ltd.

Read More..

Uniphos Enterprises Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Uniphos Enterprises Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0 1 0 0 1 0 0 0 0 0
Other Income 50 1 1 1 40 1 1 1 40 1
Total Income 50 2 1 1 42 1 1 1 40 1
Total Expenditure 1 2 1 1 2 1 1 1 1 1
Operating Profit 49 0 -0 0 40 0 0 0 40 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 49 0 -0 0 39 -0 0 -0 39 -0
Provision for Tax 2 0 0 0 0 1 -0 0 0 -0
Profit After Tax 47 0 -0 0 39 -1 0 -0 39 -0
Adjustments 0 0 0 0 0 -0 0 0 0 0
Profit After Adjustments 47 0 -0 0 39 -1 0 -0 39 -0
Adjusted Earnings Per Share 6.8 0 -0.1 0 5.7 -0.1 0.1 -0 5.7 -0

Uniphos Enterprises Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 1 9 2 0 0 0 0 0 1 1 1 0
Other Income 2 7 11 14 13 20 24 23 26 57 43 43
Total Income 3 16 13 14 13 20 24 24 27 58 45 43
Total Expenditure 3 10 3 1 2 2 3 3 4 4 4 4
Operating Profit 1 7 10 12 11 18 21 20 23 54 40 40
Interest 11 8 1 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -10 -2 9 12 11 18 21 20 23 54 40 39
Provision for Tax 0 0 0 -0 0 0 0 0 -1 -1 0 0
Profit After Tax -10 -2 9 12 11 18 21 20 24 55 39 39
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -10 -2 9 12 11 18 21 20 24 55 39 39
Adjusted Earnings Per Share -4 -0.2 1.2 1.7 1.6 2.5 3 2.9 3.5 7.9 5.6 5.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR -26% 26% 17% 45%
PAT CAGR -29% 25% 17% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 3% 16% 9% 20%
ROE Average 1% 2% 1% 0%
ROCE Average 1% 1% 1% 3%

Uniphos Enterprises Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 191 263 272 283 2067 2090 2698 1518 2715 3181 2998
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 57 120 97
Total Current Liabilities 92 18 10 0 0 0 0 1 0 1 1
Total Liabilities 282 281 282 284 2067 2090 2698 1519 2772 3302 3095
Fixed Assets 174 174 174 174 175 0 0 0 0 0 0
Other Non-Current Assets 106 106 106 107 1878 2059 2659 1459 2711 3242 3042
Total Current Assets 3 1 2 3 14 31 38 59 61 60 53
Total Assets 282 281 282 284 2067 2090 2698 1519 2772 3302 3095

Uniphos Enterprises Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 4 2 1 2 2 1 6 1 43 4 2
Cash Flow from Operating Activities 4 5 -8 -2 -2 -3 -3 -2 -5 1 -1
Cash Flow from Investing Activities 2 7 10 14 -0 9 -2 44 -34 20 41
Cash Flow from Financing Activities -7 -14 -1 -11 0 0 0 0 0 -24 -39
Net Cash Inflow / Outflow -1 -2 1 1 -2 5 -5 42 -38 -3 -0
Closing Cash & Cash Equivalent 2 1 2 2 1 6 1 43 4 2 1

Uniphos Enterprises Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -3.96 -0.23 1.23 1.7 1.62 2.54 2.99 2.89 3.52 7.85 5.64
CEPS(Rs) -3.94 -0.23 1.23 1.7 1.63 2.55 2.99 2.89 3.52 7.86 5.73
DPS(Rs) 0 0 0 0 0 0 0 0 3.4 5.65 6.5
Book NAV/Share(Rs) 17.87 16.98 18.21 19.91 276.32 279.65 367.04 197.4 369.5 436.48 410.17
Core EBITDA Margin(%) -141.5 -6.49 -46.73 0 0 0 0 -1302.78 -368.01 -255.85 -194.48
EBIT Margin(%) 55.82 72.12 505.19 0 0 0 0 9006.61 2809.85 4414.68 2691.85
Pre Tax Margin(%) -919.53 -17.97 445.63 0 0 0 0 9006.61 2809.85 4414.68 2691.85
PAT Margin (%) -919.53 -17.97 445.63 0 0 0 0 8851.15 2936.36 4469.12 2664.95
Cash Profit Margin (%) -914.73 -17.43 448.09 0 0 0 0 8867.2 2940.51 4471.8 2705.89
ROA(%) -3.51 -0.58 3.03 4.17 0.96 0.85 0.87 0.95 1.14 1.8 1.23
ROE(%) -19.96 -1.99 6.96 8.9 1.09 0.91 0.92 1.02 1.24 1.95 1.33
ROCE(%) 0.44 4.95 7.29 8.85 1.09 0.93 0.94 1.04 1.19 1.92 1.35
Receivable days 0 0 0 0 0 0 0 0 0 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 1572.11 4.53 18.36 0 0 0 0 684.19 189.2 90.49 143.3
PER(x) 0 0 23.58 19.84 44.15 32.48 37.36 13.62 24.15 16.86 27.29
Price/Book(x) 1 1.1 1.59 1.69 0.26 0.3 0.3 0.2 0.23 0.3 0.38
Dividend Yield(%) 0 0 0 0 0 0 0 0 4 4.27 4.22
EV/Net Sales(x) 120.66 15.39 109.27 0 0 0 0 1016.53 703.89 747.83 705.43
EV/Core EBITDA(x) 199.06 21.18 21.53 18.91 43.9 31.42 36.49 11.27 25.01 16.93 25.81
Net Sales Growth(%) -88.2 719.34 -78.93 -100 0 0 0 0 267.15 46.73 20.47
EBIT Growth(%) -93.74 958.56 47.61 26.04 -7.51 60.16 17.44 -3.58 14.54 130.53 -26.54
PAT Growth(%) -958.16 83.98 622.49 38.4 -4.52 57.05 17.39 -3.32 21.8 123.32 -28.16
EPS Growth(%) -958.12 94.08 622.57 38.4 -4.51 57.05 17.39 -3.32 21.8 123.32 -28.16
Debt/Equity(x) 1.96 0.09 0.08 0 0 0 0 0 0 0 0
Current Ratio(x) 0.03 0.06 0.22 13.88 91.19 189.65 219.18 83.41 229.58 100.1 50.39
Quick Ratio(x) 0.03 0.06 0.22 13.88 91.19 189.65 219.18 83.41 229.58 100.1 50.39
Interest Cover(x) 0.06 0.8 8.48 31.87 0 0 0 0 0 0 0
Total Debt/Mcap(x) 1.97 0.08 0.05 0 0 0 0 0 0 0 0

Uniphos Enterprises Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 73.77 73.77 73.77 73.77 73.77 73.77 73.77 73.77 73.77 73.77
FII 15.39 15.39 15.39 15.38 15.43 15.58 15.69 15.74 15.74 15.74
DII 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Public 10.83 10.83 10.83 10.83 10.78 10.63 10.52 10.47 10.48 10.48
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.4 times its book value
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 2% over the last 3 years.
  • Debtor days have increased from 90.49 to 143.3days.
  • Earnings include an other income of Rs. 43 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Uniphos Enterprises News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!